- Hydrocolloid dressings, composed of gel-forming agents such as carboxymethylcellulose, are increasingly recognized as essential components in modern wound care due to their ability to maintain a moist environment that supports autolytic debridement and accelerates healing in both acute and chronic wounds
- The escalating demand for hydrocolloid dressings is primarily fuelled by the rising incidence of chronic wounds, such as pressure ulcers and diabetic foot ulcers, coupled with the growing aging population and increasing number of surgical procedures globally
- North America dominates the hydrocolloid dressing market with the largest revenue share of 40.6% in 2024, attributed to a well-established healthcare infrastructure, high awareness among patients and providers, and strong presence of leading wound care companies
- Asia-Pacific is expected to be the fastest-growing region in the hydrocolloid dressing market during the forecast period, registering a CAGR of 8.7% from 2025 to 2032. This growth is driven by rising healthcare expenditure, an increasing diabetic population, and expanding access to advanced wound care in emerging economies such as China and India
- The chronic wound segment dominates the hydrocolloid dressing market with a market share of 44.7% in 2024, driven by the growing prevalence of diabetes-related wounds and pressure injuries, particularly in elderly populations, prompting healthcare providers to favour hydrocolloid products for their cost-effectiveness and therapeutic benefits
